These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31568020)

  • 1. Dramatic thrombolysis after rapid injection of tissue plasminogen activator: A case report.
    Park JS; Hwang J
    Medicine (Baltimore); 2019 Sep; 98(38):e17331. PubMed ID: 31568020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intracerebral and subarachnoid hemorrhages after administration of recombinant tissue plasminogen activator in a patient with acute ischemicstroke due to anterior cerebral artery dissection: a case report].
    Ueyama K; Koyama S; Nakamura R
    Brain Nerve; 2011 Jun; 63(6):605-10. PubMed ID: 21613663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation.
    Tountopoulou A; Ahl B; Weissenborn K; Becker H; Goetz F
    Neuroradiology; 2008 Jan; 50(1):75-83. PubMed ID: 17917723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Emergency carotid artery stenting within 24 hours after intravenous thrombolysis for acute ischemic stroke: a case report].
    Inoue A; Tagawa M; Nishikawa M; Kumon Y; Watanabe H; Ohnishi T
    No Shinkei Geka; 2013 Jul; 41(7):609-17. PubMed ID: 23824351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety Evaluation on Arterial Thrombolysis in Treating Acute Cerebral Infarction.
    Shen B; Liu Q; Gu Y; Wang Y; Zhang Z
    Cell Biochem Biophys; 2015 Nov; 73(2):297-304. PubMed ID: 27352315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical clot disruption following intravenous recombinant tissue plasminogen activator administration in non-responders.
    Kawakami T; Terakawa Y; Tsuruno T; Murata T; Nishio A; Ohata K
    Neurol Med Chir (Tokyo); 2010; 50(3):183-91. PubMed ID: 20339266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tirofiban combined with rt-PA intraarterial thrombolysis improves the recanalization rate of acute middle cerebral artery occlusion in rabbits.
    Yu YJ; Xiong W
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2888-2895. PubMed ID: 29771445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction.
    Kalbfleisch J; Thadani U; LittleJohn JK; Brown G; Magorien R; Kutcher M; Taylor G; Maddox WT; Campbell WB; Perry J
    Am J Cardiol; 1992 May; 69(14):1120-7. PubMed ID: 1575179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients.
    Lee KY; Han SW; Kim SH; Nam HS; Ahn SW; Kim DJ; Seo SH; Kim DI; Heo JH
    Stroke; 2007 Jan; 38(1):192-3. PubMed ID: 17110611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography.
    Nichols C; Khoury J; Brott T; Broderick J
    J Stroke Cerebrovasc Dis; 2008; 17(2):64-8. PubMed ID: 18346647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can catheter-directed thrombolysis be applied to acute lower extremity artery embolism after recent cerebral embolism from atrial fibrillation?
    Si TG; Guo Z; Hao XS
    Clin Radiol; 2008 Oct; 63(10):1136-41. PubMed ID: 18774361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator.
    Johns JA; Gold HK; Leinbach RC; Yasuda T; Gimple LW; Werner W; Finkelstein D; Newell J; Ziskind AA; Collen D
    Circulation; 1988 Sep; 78(3):546-56. PubMed ID: 3136953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of acute basilar artery occlusion: intraarterial thrombolysis alone vs bridging therapy.
    Nagel S; Schellinger PD; Hartmann M; Juettler E; Huttner HB; Ringleb P; Schwab S; Köhrmann M
    Stroke; 2009 Jan; 40(1):140-6. PubMed ID: 18927446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
    J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.
    Ishihara H; Torii H; Imoto H; Oka F; Sadahiro H; Suzuki M
    J Stroke Cerebrovasc Dis; 2014; 23(10):e457-e459. PubMed ID: 25280819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator.
    Jang IK; Gold HK; Leinbach RC; Fallon JT; Collen D
    Circ Res; 1990 Dec; 67(6):1552-61. PubMed ID: 2123135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours.
    Deguchi I; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):1033-1040. PubMed ID: 29221968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.